United States Proton Therapy Market Report 2018: Patients by 14 Cancer Types, Reimbursement Policies & Persons Treated at Centers 2009-2024 - ResearchAndMarkets.com

DUBLIN--()--The "United States Proton Therapy Market, Patients by 14 Cancer Types, Reimbursement Policies & Persons Treated at Centers" report has been added to ResearchAndMarkets.com's offering.

United States proton therapy market has potential to surpass US$ 16 Billion by the end of 2024

In current outlook, the United States captures more than 40 percent of Proton Beam Therapy Facility worldwide. The growth of proton therapy center in the United States is substantial and the number of new advanced proton therapy center would be launched in forecast time-frame. In the United States, almost 14 centers are in development phase (either under-construction or planning phase) will further boost the market of proton therapy.

By 14 Cancer Types - United States Proton Therapy Market & Patients:

In this report, we have done comprehensive analysis of proton therapy market and proton therapy patient numbers by 14 cancer/tumor types to understand which cancer type has more or less inclination towards proton therapy technology. In proton therapy, the frequency of patients is much higher in prostate cancer followed by pediatric cancer because of its compatibility and survival rate.

Annually Treated Patient Database by Proton Therapy Center in United States:

In this report, we have covered the number of proton therapy patients treated by each proton therapy center since their inception and till 2017 on annual basis. According to the research findings, proton therapy center in United States efficiently manage the patients. Moreover, they are also expanding their capacity, improving technical skills and changing minor technology for the treatment of more people simultaneously.

United States Reimbursement Policy regarding Proton Beam Therapy:

In this report, we have done complete assessment on the United States proton therapy reimbursement policies. We have divided the reimbursement policy into two sections; by patients and by manufacturer, stakeholder and institutions.

In this report, the researchers have studied the market in two parts a) Actual Market and b) Potential Market. The report also talks about a list of all operational and future Proton Therapy centers; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.

Key Topics Covered:

1. Executive Summary

2. Market (Actual & Potential) - United States Proton Therapy Market (2009 - 2024)

3. Number of Patients - United States Proton Therapy (2009 - 2024)

4. Cancer Types - Patients Number in United States Proton Therapy (2009 - 2024)

5. Cancer Types - United States Proton Therapy Market (2009 - 2024)

6. United States - List of Proton Therapy Centers

7. By Centers - Number of Proton Therapy Patients Treated

8. Proton Therapy - Reimbursement Policies

9. Components of a Standard Proton Therapy Center

10. Company Analysis (2010 - 2021)

11. Driving Factors for Proton Therapy

12. Challenges in Proton Therapy

Companies Mentioned

  • Elekta
  • IBA
  • Varian Medical Systems

For more information about this report visit https://www.researchandmarkets.com/research/vwv8gb/united_states?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs, Nuclear Medicine and Radiopharmacology

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs, Nuclear Medicine and Radiopharmacology